News
A CDC committee has voted to expand its respiratory syncytial virus vaccine recommendation to include all people aged 50 to ...
Governor Sarah Huckabee Sanders signed a series of bills into law on the last day of the 2025 legislative session, marking a ...
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
The CDC’s Advisory Committee on Immunization Practices voted April 16 to expand use of respiratory syncytial virus vaccines among high-risk adults. The updated recommendation calls for a single ...
The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...
1d
Zacks Investment Research on MSNGSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59GSK GSK and Pfizer PFE announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on ...
1d
Zacks Investment Research on MSNPharma Stock Roundup: J&J's Q1 Results, PFE's Obesity SetbackJ&J JNJ began the earnings season for the drug and biotech sector this week. Pfizer PFE announced the discontinuation of its ...
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results